Background:
$AMRN's drug Vascepa® (Icosapent Ethyl) proven and FDA-approved to reduce cardiovascular risks.
$AMRN's drug is called Vazkepa in the EU. They will have a market launch in Germany in Sept. Link
More EU countries to follow soon after that.
$PFE recently said to want to push Vascepa in Canada.(why do that if not for buyout?) Link
Later this year they will open in China Link
Now why I believe it will be $35:
On Aug 29th results form a COVID treatment!!! clinical trial Prepare-IT Link will be presented at ESC Congress Link ( the study got accepted as a late-breaker trial, which is a big deal!)
The doctor who is going to present it, is Dr. Rafael Diaz. To those who don't know, he is a big deal. A very important Dr. in the Cardiologist field. Here is background on him.Link
If he is presenting, the news I believe is a big deal!!! Which would make $PFE happy cause they can corner the vaccine/treatment market.
If Vascepa is proven as a COVID treatment on Aug 29th, my god buckle up. Anything under $35 in my opnion is heresy. Still, do your own due dilagence. All facts are my interpertation of said facts and are my own opinion. GLTA
FYI: Last moment to trade once the news breaks on Aug 29th and before US markets open will be the Frankfurt market Link
Submitted August 21, 2021 at 12:56AM by stillness0072 https://ift.tt/3glI8O6
